10-K Decoder · All companies

TG Therapeutics, Inc.

TGTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$616M$329M+87.3%
Operating income$123M$41.9M+194%
Net income$447M$23.4M+1,813%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$260M$162M+60.7%
Operating income$85.9M$29.4M+192%
Net income$55.5M$391M−85.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was TG Therapeutics's revenue in FY2025?
$616M in FY2025 (Fiscal year ended Dec 31, 2025), +87.3% vs $329M a year earlier, per its 10-K filed Feb 2026.
Was TG Therapeutics profitable in FY2025?
Yes: net income was $447M and operating income $123M in FY2025.
What was TG Therapeutics's revenue in Q3 2026?
$260M (+60.7% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.